Redhill Biopharma (Redhill Biopharma) Change In Inventory : $2.55 Mil (TTM As of Jun. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Redhill Biopharma Change In Inventory?

Redhill Biopharma's change in inventory for the quarter that ended in Jun. 2023 was $-3.31 Mil. It means Redhill Biopharma's inventory increased by $3.31 Mil from Mar. 2023 to Jun. 2023 .

Redhill Biopharma's change in inventory for the fiscal year that ended in Dec. 2023 was $2.39 Mil. It means Redhill Biopharma's inventory declined by $2.39 Mil from Dec. 2022 to Dec. 2023 .

Redhill Biopharma's Total Inventories for the quarter that ended in Jun. 2023 was $4.94 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Redhill Biopharma's Days Inventory for the quarter that ended in Jun. 2023 was 611.24.

Inventory Turnover measures how fast the company turns over its inventory within a year. Redhill Biopharma's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.15.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Redhill Biopharma's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 3.01.

Redhill Biopharma Change In Inventory Historical Data

The historical data trend for Redhill Biopharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redhill Biopharma Change In Inventory Chart

Redhill Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-1.11

-4.64

-8.29

3.80

2.39

Redhill Biopharma Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-0.87	1.58	5.15	-3.31	-

Redhill Biopharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.55 Mil.

Redhill Biopharma (NAS:RDHL) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Redhill Biopharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	5.399	/	0.806	*	365 / 4
	=	611.24

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Redhill Biopharma's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.806	/	5.399
	=	0.15

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Redhill Biopharma's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	5.399	/	1.796
	=	3.01

Redhill Biopharma Change In Inventory Related Terms

Thank you for viewing the detailed overview of Redhill Biopharma's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Redhill Biopharma (Redhill Biopharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Redhill Biopharma Ltd (NAS:RDHL) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

2RH0:Germany 2RH0:Germany

Address

21 Ha’arba’a Street, Tel Aviv, ISR, 6473921

Website

https://www.redhillbio.com

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults, Talicia for the treatment of Helicobacter pylori infection in adults, and Aemcolo for the treatment of travelers' diarrhea in adults. Its key clinical late-stage development programs include RHB-104 for Crohn's disease; RHB-204, for pulmonary nontuberculous mycobacteria infections; RHB-102 (Bekinda) with positive results from a first Phase 3 study for acute gastroenteritis and gastritis; Opaganib (Yeliva); RHB-106, an encapsulated bowel preparation and RHB-107, a Phase 2-stage serine protease inhibitor targeting cancer and inflammatory gastrointestinal diseases.